Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study

AIMS: Nonvitamin K antagonist oral anticoagulants (NOACs) are now available for the prevention of stroke in patients with atrial fibrillation (AF) as an alternative to vitamin K antagonists (VKA) and aspirin. The comparative effectiveness and safety in daily practice of these different drug classes...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Clin Pharmacol
Auteurs principaux: Gieling, Emilie M., van den Ham, Hendrika A., van Onzenoort, Hein, Bos, Jacqueline, Kramers, Cornelis, de Boer, Anthonius, de Vries, Frank, Burden, Andrea M.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Pharmacoepidemiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510083/
https://ncbi.nlm.nih.gov/pubmed/28205318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13265
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires